Integrative proteomics reveals an increase in non-degradative ubiquitylation in activated CD4+ T cells.
Joseph M DybasClaire E O'LearyHua DingLynn A SpruceSteven H SeeholzerPaula M OliverPublished in: Nature immunology (2019)
Despite gathering evidence that ubiquitylation can direct non-degradative outcomes, most investigations of ubiquitylation in T cells have focused on degradation. Here, we integrated proteomic and transcriptomic datasets from primary mouse CD4+ T cells to establish a framework for predicting degradative or non-degradative outcomes of ubiquitylation. Di-glycine remnant profiling was used to reveal ubiquitylated proteins, which in combination with whole-cell proteomic and transcriptomic data allowed prediction of protein degradation. Analysis of ubiquitylated proteins identified by di-glycine remnant profiling indicated that activation of CD4+ T cells led to an increase in non-degradative ubiquitylation. This correlated with an increase in non-proteasome-targeted K29, K33 and K63 polyubiquitin chains. This study revealed over 1,200 proteins that were ubiquitylated in primary mouse CD4+ T cells and highlighted the relevance of non-proteasomally targeted ubiquitin chains in T cell signaling.
Keyphrases
- single cell
- rna seq
- label free
- cancer therapy
- mass spectrometry
- biofilm formation
- type diabetes
- staphylococcus aureus
- small molecule
- electronic health record
- cell therapy
- machine learning
- genome wide
- cystic fibrosis
- gene expression
- big data
- pseudomonas aeruginosa
- dna methylation
- mesenchymal stem cells
- artificial intelligence
- adipose tissue
- deep learning
- candida albicans